CAR T-cell therapy for relapsed or refractory mantle-cell lymphoma
Lancet Oncol
.
2020 May;21(5):e239.
doi: 10.1016/S1470-2045(20)30231-X.
Epub 2020 Apr 9.
Author
Robert Stirrups
PMID:
32278358
DOI:
10.1016/S1470-2045(20)30231-X
No abstract available
Publication types
Comment
MeSH terms
Adult
Humans
Immunotherapy, Adoptive*
Lymphoma, Mantle-Cell*